PPARG and type 2 diabetes mellitus: This paradigm has been previously demonstrated for T2D in the context of PPARG and insulin resistance, in which simultaneous effects of rare coding variants on T2D risk (when analyzed in a genetic study) and adipogenesis (when introduced into a cellular assay) validated the gene’s mechanism of action [41].